| Literature DB >> 28229048 |
Alejandro Cabezas-Cruz1, Pilar Alberdi2, James J Valdés3, Margarita Villar2, José de la Fuente4.
Abstract
The obligate intracellular pathogen, Anaplasma phagocytophilum, is the causative agent of human, equine, and canine granulocytic anaplasmosis and tick-borne fever (TBF) in ruminants. A. phagocytophilum has become an emerging tick-borne pathogen in the United States, Europe, Africa, and Asia, with increasing numbers of infected people and animals every year. It has been recognized that intracellular pathogens manipulate host cell metabolic pathways to increase infection and transmission in both vertebrate and invertebrate hosts. However, our current knowledge on how A. phagocytophilum affect these processes in the tick vector, Ixodes scapularis is limited. In this study, a genome-wide search for components of major carbohydrate metabolic pathways was performed in I. scapularis ticks for which the genome was recently published. The enzymes involved in the seven major carbohydrate metabolic pathways glycolysis, gluconeogenesis, pentose phosphate, tricarboxylic acid cycle (TCA), glyceroneogenesis, and mitochondrial oxidative phosphorylation and β-oxidation were identified. Then, the available transcriptomics and proteomics data was used to characterize the mRNA and protein levels of I. scapularis major carbohydrate metabolic pathway components in response to A. phagocytophilum infection of tick tissues and cultured cells. The results showed that major carbohydrate metabolic pathways are conserved in ticks. A. phagocytophilum infection inhibits gluconeogenesis and mitochondrial metabolism, but increases the expression of glycolytic genes. A model was proposed to explain how A. phagocytophilum could simultaneously control tick cell glucose metabolism and cytoskeleton organization, which may be achieved in part by up-regulating and stabilizing hypoxia inducible factor 1 alpha in a hypoxia-independent manner. The present work provides a more comprehensive view of the major carbohydrate metabolic pathways involved in the response to A. phagocytophilum infection in ticks, and provides the basis for further studies to develop novel strategies for the control of granulocytic anaplasmosis.Entities:
Keywords: Anaplasma phagocytophilum; Ixodes scapularis; glucose metabolism; proteomics; transcriptomics
Mesh:
Substances:
Year: 2017 PMID: 28229048 PMCID: PMC5293764 DOI: 10.3389/fcimb.2017.00023
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Annotation of carbohydrate metabolic enzymes identified in the .
| Hexokinase | HXK | 454 | ||
| Phosphoglucose isomerase | PGI | 543 | ||
| Phosphofructokinase | PFK | 55 | ||
| Fructose-bisphosphate aldolase A | ALDA | 364 | ||
| Glyceraldehyde 3-phosphate dehydrogenase | GAPDH | 334 | ||
| Phosphoglycerate kinase 1 | PGK1 | 415 | ||
| Phosphoglycerate mutase (cofactor-independent) | iPGM | 510 | ||
| Enolase | ENOL | 199 | ||
| Pyruvate kinase | PK | 538 | ||
| Glucose 6-phosphatase (1) | G6Pase (1) | 356 | ||
| Glucose 6-phosphatase (2) | G6Pase (2) | 282 | ||
| Fructose-1,6-bisphosphatase | FBP | 338 | ||
| Phosphoenolpyruvate carboxykinase mitochondrial (1) | PEPCK-M (1) | 503 | ||
| Phosphoenolpyruvate carboxykinase mitochondrial (2) | PEPCK-M (2) | 288 | ||
| Phosphoenolpyruvate carboxykinase 1 cytoplasmatic | PEPCK-C | 165 | ||
| Phosphoenolpyruvate carboxykinase | PEPCK | 192 | ||
| Pyruvate carboxylase | PC | Not found | Not found | … |
| Glucose 6-phosphate dehydrogenase | G6PD | 523 | ||
| 6-phosphogluconolactonase | PGLS | 101 | ||
| 6-phosphogluconate dehydrogenase | 6PGD | 507 | ||
| Ribose 5-Phosphate Isomerase | RPI | 172 | ||
| Ribulose 5-Phosphate 3-Epimerase | RPPE | 236 | ||
| Transketolase | TKT | Not found | Not found | … |
| Transaldolase | TALDO | 219 | ||
| Pyruvate dehydrogenase E1 | PDE1 | 393 | ||
| Citrate synthase | CS | 471 | ||
| Aconitase | ACON | 65 | ||
| Isocitrate dehydrogenase 3 α subunit | IDH3A | 362 | ||
| Isocitrate dehydrogenase 3 β subunit | IDH3B | 207 | ||
| Isocitrate dehydrogenase 3 γ-subunit (I) | IDH3G1 | 132 | ||
| Isocitrate dehydrogenase 3 γ-subunit (II) | IDH3G2 | 365 | ||
| 2-oxoglutarate dehydrogenase E1 | OXOE1 | 831 | ||
| GTP/ATP-specific Succinyl-CoA synthetase—α subunit | B/A-SCS-α | 217 | ||
| ATP-specific Succinyl-CoA synthetase—β subunit | A-SCS-β | 425 | ||
| GTP-specific Succinyl-CoA synthetase—β subunit | G-SCS-β | 422 | ||
| Succinate dehydrogenase flavoprotein subunit | SDHA | 608 | ||
| Succinate dehydrogenase iron-sulfur subunit | SDHB | 286 | ||
| Succinate dehydrogenase cytochrome b560 subunit | SDHC | 132 | ||
| Succinate dehydrogenase cytochrome b small subunit | SDHD | 208 | ||
| Fumarase hydratase mitochondrial | FH | 481 | ||
| Malate dehydrogenase 1 cytoplasmatic | MDH1 | 302 | ||
| Malate dehydrogenase 2 mitochondrial | MDH2 | 340 | ||
| Pyruvate dehydrogenase kinase | PDK | 344 | ||
| Pyruvate dehyrogenase phosphatase catalytic subunit 1 | PDPC1 | 401 | ||
| NADH dehydrogenase (ubiquinone) iron-sulfur protein 7 | NDUS7 | 162 | ||
| NADH dehydrogenase (ubiquinone) iron-sulfur protein 8 | NDUS8 | 210 | ||
| NADH dehydrogenase (ubiquinone) flavoprotein 2 | NDUV2 | 244 | ||
| NADH dehydrogenase (ubiquinone) iron-sulfur protein 3 | NDUS3 | 268 | ||
| NADH dehydrogenase (ubiquinone) iron-sulfur protein 2 | NDUS2 | 462 | ||
| NADH dehydrogenase (ubiquinone) flavoprotein 1 | NDUV1 | 477 | ||
| NADH-ubiquinone oxidoreductase 75 kDa subunit | NDUS1 | 729 | ||
| NADH-ubiquinone oxidoreductase chain 1 | ND1 | 339 | ||
| NADH-ubiquinone oxidoreductase chain 2 | ND2 | Not found | Not found | … |
| NADH-ubiquinone oxidoreductase chain 3 | ND3 | Not found | Not found | … |
| NADH-ubiquinone oxidoreductase chain 4 | ND4 | Not found | Not found | … |
| NADH-ubiquinone oxidoreductase chain 4L | ND4L | Not found | Not found | … |
| NADH-ubiquinone oxidoreductase chain 5 | ND5 | 385 | ||
| NADH-ubiquinone oxidoreductase chain 6 | ND6 | Not found | Not found | … |
| Succinate dehydrogenase flavoprotein subunit | SDHA | 608 | ||
| Succinate dehydrogenase iron-sulfur subunit | SDHB | 286 | ||
| Succinate dehydrogenase cytochrome b560 subunit | SDHC | 132 | ||
| Succinate dehydrogenase cytochrome b small subunit | SDHD | 208 | ||
| Cytochrome b-c1 complex subunit 1 | QCR1 | Not found | Not found | … |
| Cytochrome b-c1 complex subunit 2 | QCR2 | Not found | Not found | … |
| Cytochrome b | CYTB | 385 | ||
| Cytochrome c1 | CYTC1 | 251 | ||
| Cytochrome b-c1 complex subunit Rieske | RIESKE | 229 | ||
| Cytochrome b-c1 complex subunit 6 | QCR6 | 80 | ||
| Cytochrome b-c1 complex subunit 7 | QCR7 | 81 | ||
| Cytochrome b-c1 complex subunit 8 | QCR8 | 82 | ||
| Cytochrome b-c1 complex subunit 9 | QCR9 | 59 | ||
| Cytochrome b-c1 complex subunit 10 | QCR10 | Not found | Not found | … |
| Cytochrome b-c1 complex subunit 11 | QCR11 | Not found | Not found | … |
| Cytochrome c oxidase subunit 1 | COX1 | Not found | 276 | |
| Cytochrome c oxidase subunit 2 | COX2 | 244 | ||
| Cytochrome c oxidase subunit 3 | COX3 | 278 | ||
| Cytochrome c oxidase subunit 4 | COX4 | Not found | 179 | |
| Cytochrome c oxidase subunit 5A | COX5A | 153 | ||
| Cytochrome c oxidase subunit 5B | COX5B | 124 | ||
| Cytochrome c oxidase subunit 6A | COX6A | 111 | ||
| Cytochrome c oxidase subunit 6B | COX6B | 82 | ||
| Cytochrome c oxidase subunit 6C | COX6C | 76 | ||
| Cytochrome c oxidase subunit 7 | COX7 | Not found | Not found | … |
| Cytochrome c oxidase subunit 8 | COX8 | 68 | ||
| ATP synthase subunit α 1 (F1) | ATPSA1 | 555 | ||
| ATP synthase subunit α 2 (F1) | ATPSA2 | 355 | ||
| ATP synthase subunit β (F1) | ATPSB | 563 | ||
| ATP synthase subunit γ (F1) | ATPSG | 314 | ||
| ATP synthase subunit δ (F1) | ATPSD | 168 | ||
| ATP synthase subunit ϵ (F1) | ATPSE | 55 | ||
| ATP synthase subunit A (F0) | ATPA | Not found | Not found | … |
| ATP synthase subunit B (F0) | ATPB | 264 | ||
| ATP synthase subunit C (F0) | ATPC | 152 | ||
| Acyl-CoA dehydrogenase family member 9 | ACAD9 | 433 | ||
| Short-chain specific acyl-CoA dehydrogenase (1) | SCAD1 | 76 | ||
| Short-chain specific acyl-CoA dehydrogenase (2) | SCAD2 | 410 | ||
| Medium-chain acyl-CoA dehydrogenase | MCAD | 275 | ||
| Very long-chain acyl-CoA dehydrogenase | VLCAD | 254 | ||
| Enoyl-CoA hydratase | ECHD | 290 | ||
| 3-hydroxyacyl CoA dehydrogenase | 3HCD | 310 | ||
| 3-ketoacyl-CoA thiolase (Thiolase I) | THIOL | 406 | ||
| Triosephosphate isomerase | TPI | 247 | ||
| Glycerol-3-phosphate dehydrogenase cytoplasmic | GPDHc | 340 | ||
Figure 1Model of carbohydrate metabolism in . The main enzymes involved in Glycolysis (GLY), Gluconeogenesis (GLN), Pentose phosphate pathway (PPP), Tricarboxylic acid cycle (TCA), Oxidative phosphorylation (OXPHOS) complex I to V, β-Oxidation and Glyceroneogenesis (GLYCENEO) and present in the genome of I. scapularis (Table 1) are shown. The names and number of carbon molecules (Red circles) of the metabolic intermediates of these metabolic pathways are also shown. The names of the enzymes were abbreviated for the different pathways as GLY: Hexokinase (HXK), Phosphoglucose isomerase (PGI), Phosphofructokinase (PFK), Fructose-bisphosphate aldolase A (ALDA), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), Phosphoglycerate kinase 1 (PGK1), Phosphoglycerate mutase (cofactor-independent) (iPGM), Enolase (ENOL), Pyruvate kinase (PK); GLN: Glucose 6-phosphatase (1) (G6Pase (1)), Fructose-1,6-bisphosphatase (FBP), Phosphoenolpyruvate carboxykinase mitochondrial (1) (PEPCK-M (1)), Phosphoenolpyruvate carboxykinase mitochondrial (2) (PEPCK-M (2)), Phosphoenolpyruvate carboxykinase 1 cytoplasmatic (PEPCK-C), Pyruvate carboxylase (PC); PPP: Glucose 6-phosphate dehydrogenase (G6PD), 6-phosphogluconolactonase (PGLS), 6-phosphogluconate dehydrogenase (6PGD), Ribose 5-Phosphate Isomerase (RPI), Ribulose 5-Phosphate 3-Epimerase (RPPE), Transketolase (TKT), Transaldolase (TALDO); β-Oxidation: Acyl-CoA dehydrogenase family member 9 (ACAD9), Short-chain specific acyl-CoA dehydrogenase (1) (SCAD1), Short-chain specific acyl-CoA dehydrogenase (2) (SCAD2), Medium-chain acyl-CoA dehydrogenase (MCAD), Very long-chain acyl-CoA dehydrogenase (VLCAD), Enoyl-CoA hydratase (ECHD), 3-hydroxyacyl CoA dehydrogenase (3HCD), 3-ketoacyl-CoA thiolase (Thiolase I) (THIOL); GLYCENEO: Triosephosphate isomerase (TPI), Glycerol-3-phosphate dehydrogenase cytoplasmic (GPDHc); OXPHOS: Complex I: NADH dehydrogenases (NDUS7, NDUS8, NDUV2, NDUS3, NDUS2 and NDUV1), NADH-ubiquinone oxidoreductases (NDUS1, ND1 and ND5); Complex II: Succinate dehydrogenases (SDHA, SDHB, SDHC, SDHD); Complex III: Cytochrome b and b-c1 complexe subunits (QCR1, QCR2, CYTB, RIESKE, QCR6, QCR7, QCR8, QCR9, QCR10, QCR11), Cytochrome c1 (CYTC1); Complex IV: Cytochrome c oxidase subunits (COX1, COX2, COX3, COX5A, COX5B, COX6A, COX6B, COX6C, COX8); Complex V: ATP synthase subunits (ATPSA1, ATPSA2, ATPSB, ATPSG, ATPSD, ATPSE, ATPB, ATPC).
Figure 2. Comparison of carbohydrate metabolism enzymes mRNA and protein levels in I. scapularis nymphs (N), female midguts (G), female salivary glands (SG), and ISE6 cells (ISE6) in response to A. phagocytophilum infection. Transcriptomics and proteomics data were obtained from previously published datasets available on the Dryad repository database, NCBI's Gene Expression Omnibus database and ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD002181 and doi: 10.6019/PXD002181 (Ayllón et al., 2015; Villar et al., 2015). Name of enzymes are abbreviated as in Table 1 and Figure 1.
Figure 3. Comparison of glucose transporters mRNA and protein levels in I. scapularis nymphs (N), female midguts (G), female salivary glands (SG) and ISE6 cells (ISE6) in response to A. phagocytophilum infection. Transcriptomics and proteomics data were obtained from previously published datasets available on the Dryad repository database, NCBI' Gene Expression Omnibus database and ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD002181 and doi: 10.6019/PXD002181 (Ayllón et al., 2015; Villar et al., 2015).
Figure 4Carbohydrate metabolic pathways in response to . Protein representation of enzymes of the I. scapularis carbohydrate metabolic pathways in response to A. phagocytophilum infection is shown. Similar changes in mRNA and protein levels are highlighted (triangles). Code: green, up-regulated/over-represented; red, down-regulated/under-represented.
Figure 5Carbohydrate metabolic pathways in response to . Protein representation of enzymes of the I. scapularis carbohydrate metabolic pathways in response to A. phagocytophilum infection is shown. Similar changes in mRNA and protein levels are highlighted (triangles). Code: green, up-regulated/over-represented; red, down-regulated/under-represented.
Figure 6Modeling of the HIF-1α-HIF-1β-HRE complex. (A) HIF-1α (red) and HIF-1β (green) monomers with their respective domains labeled. (B) Ternary complex of both monomers plus the hypoxia response element (HRE; orange). The inset shows the conserved Lys residue that interacts with the thymine (T) of HRE.
Annotation of PI3K-mTOR pathway components identified in the .
| RAC-alpha serine/threonine-protein kinase | AKT2 | 371 | ||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit α | p110α | 617 | ||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit β | p110β | 491 | ||
| Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing α (1) | PI3K-C2α1 | 1638 | ||
| Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing α (2) | PI3K-C2α2 | 1142 | ||
| Phosphatidylinositol 3-kinase regulatory subunit α | p85α | 427 | ||
| 3- phosphoinositide-dependent protein kinase 1 | PDK1 | 521 | ||
| Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 | SHIP1 | 535 | ||
| Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase PTEN | PTEN | 363 | ||
| Arf-GAP with GTPase, ANK repeat and PH domain-containing protein | PIKE | 558 | ||
| Glycogen synthase kinase 3 β (2) | GSK3β2 | 588 | ||
| Hamartin | TSC1 | 874 | ||
| Tuberin | TSC2 | 429 | ||
| Serine/threonine kinase 11 (1) | LKB1/STK11A | 170 | ||
| Serine/threonine kinase 11 (2) | LKB1/STK11B | 293 | ||
| AMP-activated protein kinase α | AMPKα | 510 | ||
| AMP-activated protein kinase β | AMPKβ | 183 | ||
| AMP-activated protein kinase γ | AMPKγ | 154 | ||
| Ras homolog enriched in brain | RHEB | 182 | ||
| Regulatory-associated protein of mTOR | RAPTOR | 995 | ||
| G protein β subunit-like | GβL | 324 | ||
| Rapamycin-insensitive companion of mTOR | RICTOR | 987 | ||
| Phosphatidylinositol 3-kinase catalytic subunit type 3 | Vps34 | 864 | ||
| Serine/threonine-protein kinase VPS15 | Vps15 | 1351 | ||
| Pleckstrin homology domain-containing, family O member 1 | CKIP1 | 359 | ||
| Casein kinase 2 subunit α | CK2α | 436 | ||
| Casein kinase 2 subunit β | CK2β | 222 | ||
| Ribosomal protein S6 kinase beta-1 (p70s6 kinase) | S6K1/p70s6K | 344 |
Figure 7. Comparison of PI3K-mTOR pathway components mRNA and protein levels in I. scapularis nymphs (N), female midguts (G), female salivary glands (SG) and ISE6 cells (ISE6) in response to A. phagocytophilum infection. Transcriptomics and proteomics data were obtained from previously published datasets available on the Dryad repository database, NCBI's Gene Expression Omnibus database and ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD002181 and doi: 10.6019/PXD002181 (Ayllón et al., 2015; Villar et al., 2015). Name of enzymes are abbreviated as in Table 2. (*) In this figure, PDK1 stands for 3- phosphoinositide-dependent protein kinase 1, and not Pyruvate dehydrogenase kinase 1, which is also abbreviated as PDK1.
Figure 8Functional analysis supports a role for glycolysis during A. phagocytophilum-infected ISE6 cells were left untreated (Control) or treated for 24 or 48 h with 2-Deoxy-D-Glucose to inhibit glycolysis, LY294002 to inhibit the PI3K, Chetomin to inhibit the activity of HIF-1α or Deferoxamine mesylate to activate HIF-1α. HIF-1α activity was determined in cell lysates, and O.D. 450 nm values were shown as average + SD and compared between treated and untreated control cells by Student's t-test with unequal variance (P = 0.05; N = 4 biological replicates). (B) A. phagocytophilum DNA levels were characterized in LY294002-treated and untreated control cells by msp4 real-time PCR normalizing against tick 16S rDNA. Normalized Ct values were compared between treated and untreated control cells by Student's t-test with unequal variance (P < 0.01; N = 4 biological replicates). (C) Representative images of imunofluorescence analysis of uninfected and A. phagocytophilum-infected adult female I. scapularis salivary gland acini (SG). Tick tissues were stained with preimmune control serum or mouse anti-GAPDH monoclonal antibodies (green, FITC) or DAPI (blue) and superimposed (FITC+DAPI). Bars, 20 μm. Red arrows illustrate the positive staining for GAPDH in tick SG.
Figure 9Mechanistic model of carbohydrate metabolism manipulation by . We propose a mechanism by which A. phagocytophilum enhances glycolysis through HIF activation under normoxic conditions. Upon contact with the host membrane or once inside the parasitophorous vacuole, A. phagocytophilum induces the activation of PI3K and PKC that ultimately induce the expression of heat shock proteins HSP70 and HSP90, the acetyltransferase p300 and hif-1α. In normoxia, HSP70 and HSP90 stabilize HIF-1α, making possible the recruitment of p300 and HIF-1α to form a complex with HIF-1β in the nucleus. This complex activates the expression of HIF-1α target genes, which include glycolytic genes and pdk1. This mechanism will result in the increase in glycolysis and inhibition of gluconeogenesis. Furthermore, HIF activation can also leads to actin cytoskeleton reorganization. Therefore, by activating the HIF system A. phagocytophilum may regulate at the same time the tick cell carbohydrate metabolism and cytoskeleton organization. Green and red lines indicate induction/activation and inhibition, respectively. Question marks indicate that we do not know whether A. phagocytophilum induces the activation of PI3K and PKC upon contact with the host membrane or once inside the parasitophorous vacuole. Ap, A. phagocytophilum; PI3K, phosphatidylinositol 3-kinase pathway; diacylglycerol (DAG)-sensitive protein kinases C (PKC); HIF, hypoxia-inducible factor; PDK1, pyruvate dehydrogenase kinase 1; GLUT, facilitative glucose transporters; PEPCK, phosphoenolpyruvate carboxykinase.